Peter Garrett
Radiation Oncology · Indianapolis, INNPI 1225031719
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Novocure Inc. at 55.2% of the total. Reporting peaked in 2020 at $2,758 and has fallen 97.6% since, to $67 in 2023. Among radiation oncology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $43.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$3K
- Elekta, Inc.$296
- AstraZeneca$209
- Bayer$208
- Siemens Medical Solutions USA, Inc.$144
- Varian Medical Systems, Inc.$108
- plus $1K from 32 others
What the payments were for
- Speaking & faculty fees$2,50055%
- Food & beverage$2,02145%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 1 | $2,500 |
| Elekta, Inc. | 4 | $296 |
| AstraZeneca(2 entities) | 12 | $209 |
| Bayer | 12 | $208 |
| Siemens Medical Solutions USA, Inc. | 1 | $144 |
| Varian Medical Systems, Inc. | 1 | $108 |
| Novartis | 6 | $92 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $74 |
| E.r. Squibb & Sons, L.L.C. | 4 | $68 |
| Eisai Inc. | 5 | $68 |
| Daiichi Sankyo Inc. | 4 | $68 |
| Incyte Corporation | 5 | $64 |
| Tactile Systems Technology Inc | 4 | $53 |
| Astellas Pharma US Inc | 3 | $52 |
| Merck | 3 | $49 |
| Foundation Medicine, Inc. | 3 | $41 |
| Clovis Oncology, Inc. | 3 | $40 |
| Gilead | 3 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Sanofi | 2 | $34 |
| Tersera Therapeutics LLC | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| GSK | 2 | $27 |
| Amgen | 1 | $17 |
| AbbVie | 1 | $16 |
| Aurobindo Pharma USA, Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Fortovia Therapeutics, Inc. | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Mylan Institutional Inc. | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $12 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
| Seagen Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
| Dova Pharmaceuticals | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology$2,500
- Biograph mMR$144
- SOMATOM GO$144
- Treatment Planning Systems$108
How this compares
$4,526 in reported general payments places this provider in the 90th percentile of 116 radiation oncology providers in Indiana.
Other radiation oncology in Indianapolis
- Michael EatonIndianapolis$11K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Garrett JensenIndianapolis$4K
- Alexander YehIndianapolis$3K
- Erin McCammackIndianapolis$2K
- Zachary OaksIndianapolis$2K
- David KimIndianapolis$2K
- Darrel RossIndianapolis$2K
- Craig SchneiderIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.